Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood & Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)

Based on promising pilot data, a Phase II tandem autologous hematopoietic stem cell transplant (AHSCT) trial for relapsed/refractory Hodgkin Lymphoma (HL) was performed in the US intergroup setting to determine if long-term progression-free survival (PFS) could be improved. Patients were enrolled af...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biol Blood Marrow Transplant
Главные авторы: Smith, Eileen P., Li, Hongli, Friedberg, Jonathan W., Constine, Louis S., Rimsza, Lisa M., Cook, James R., Laport, Ginna G., Popplewell, Leslie L., Holmberg, Leona A., Smith, Sonali M., LeBlanc, Michael, Forman, Stephen J., Fisher, Richard I., Stiff, Patrick J.
Формат: Artigo
Язык:Inglês
Опубликовано: 2017
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5965270/
https://ncbi.nlm.nih.gov/pubmed/29289757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.12.798
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы